American Society of Hirudotherapy

Hementin

Direct fibrinogenolytic enzyme cleaving fibrinogen alpha-chain at unique sites — independent of plasmin.

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.Last Updated: May 26, 2026 · ASH Editorial · based on the books
  • Hementin80 kDa
  • Hementerin80 kDa
  • Hementin-Like Protein (HLP-1)80 kDa
  • Leech Collagenase70 kDa
  • Haemadipsa yanyuanensis Progranulin (Hy-PGRN)70 kDa
  • Leech Apyrase67 kDa
  • Calin65 kDa
  • Hyaluronidase60 kDa
  • Antithrombin III binding protein58 kDa
  • Collagenolytic Fibrinolysin55 kDa
  • Leech Thrombospondin-Like Protein50 kDa
  • LHyal (Leech Hyaluronidase)50 kDa
Molecular weight (kilodaltons) of Hementin (highlighted) alongside other characterized leech salivary compounds. Smaller proteins/peptides generally diffuse and act faster.

Mechanistic Evidence Box

Preclinical / mechanistic: Evidence is preclinical (in vitro, animal models, or mechanism-of-action research). Clinical efficacy in humans has not been established.
Page type
Compound profile
Evidence type
Preclinical / biochemical characterization
Evidence level
In vitro
Drug vs leech
Purified natural compound
Safety domains
Bleeding

Clinical translation limit

Hementin's in vitro fibrinogenolytic activity does not establish clinical efficacy as a thrombolytic. No FDA-approved derivative exists. Mechanism is preclinical/biochemical only.

Molecular Profile

Category
Fibrinolytic
Evidence tier
Preclinical
Molecular weight
80,000 Da
Source species
Haementeria ghilianii (giant Amazon leech)
Discovered
1984 · Malinconico, Budzynski et al.

Biological Targets

  • → fibrinogen Aα and Bβ chains

Key Citations

  1. Malinconico SM et al. (1984), Thromb Res · PMID 6387015

External Resources

    Related Fibrinolytic Compounds

    This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.